New research shows CGM devices can dramatically reduce the risk of life-threatening diabetes-related complications including blindness, cardiovascular disease and kidney failure for people with type 2 diabetes. More https://t.co/wRis6izSEA
Things you love to see. On Thursday we got to spend time with April Welsh as she met with a group of children newly diagnosed with type 1 who are just starting out on their journey with diabetes tech.
Nothing packs a punch more in a room full of politicians & industry leaders than a person w diabetes telling it how it is. Thanks to the amazing Katie Godden for sharing her story about the life changing impact of diabetes technology. What a rockstar! @DiabetesAus@MedtronicANZ
Powerful insights on the topics which piqued @PracticalDeeb's interest at #attd2024. It’s critical to have people with lived experience actively participating in these events. Thanks for sharing your reflections Leon!
We acknowledge the impact that media coverage may have had on people living with diabetes regarding the TGA cracking down on compounded versions of Ozempic. Nonetheless, it serves as a good reminder of the safety risks associated with unapproved products https://t.co/JFVLagPlnx
Yesterday, we convened a virtual roundtable to address the issue of people with diabetes having problems passing through airport screening when travelling with their devices.
Help us spark change: https://t.co/2lLj3M0dY8
Thousands of people living with type 2 diabetes are struggling to access Ozempic. A new breakthrough from the Florey Institute could provide a faster and cheaper way to make the medicine. #researchholdsthekey#funddiabetesresearch
▶️ Watch this video https://t.co/7dapC7HsAB
We know how important it is to support Australians living with all types of diabetes to receive the best possible healthcare. Today we released new modelling highlighting the importance of access to care https://t.co/fYyLzDq8O8
#NDW23#NationalDiabetesConversation
@RenzaS Such an incredibly important message. Such a powerful campaign. Although I am completely biased - based on the feedback I have seen, it is certainly a campaign that seems to resonate with people with diabetes, and also people who don’t have diabetes (the key target audience)